Literature DB >> 26379152

Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Madhu P Menon1, Alina Nicolae1, Hillary Meeker1, Mark Raffeld1, Liqiang Xi1, Armin G Jegalian1, Douglas C Miller2, Stefania Pittaluga1, Elaine S Jaffe1.   

Abstract

Primary central nervous system (CNS) lymphomas are relatively rare with the most common subtype being diffuse large B-cell lymphoma. Primary CNS T-cell lymphomas (PCNSTL) account for <5% of CNS lymphomas. We report the clinical, morphologic, immunophenotypic, and molecular characteristics of 18 PCNSTLs. Fifteen cases were classified as peripheral T-cell lymphoma, not otherwise specified, 2 of which were of γδ T-cell derivation and 1 was TCR silent; there was 1 anaplastic large cell lymphoma, ALK-positive and 2 anaplastic large cell lymphoma, ALK-negative. Median age was 58.5 years (range, 21 to 81 y), with an M:F ratio of 11:7. Imaging results showed that 15 patients had supratentorial lesions. Regardless of subtype, necrosis and perivascular cuffing of tumor cells were frequently observed (11/18 cases). CD3 was positive in all cases but 1; 10/17 were CD8-positive, and 5/17 were CD4-positive. Most cases studied had a cytotoxic phenotype with expression of TIA1 (13/15) and granzyme-B (9/13). Polymerase chain reaction analysis of T-cell receptor γ rearrangement confirmed a T-cell clone in 14 cases with adequate DNA quality. Next-generation sequencing showed somatic mutations in 36% of cases studied; 2 had >1 mutation, and none showed overlapping mutations. These included mutations in DNMT3A, KRAS, JAK3, STAT3, STAT5B, GNB1, and TET2 genes, genes implicated previously in other T-cell neoplasms. The outcome was heterogenous; 2 patients are alive without disease, 4 are alive with disease, and 6 died of disease. In conclusion, PCNSTLs are histologically and genomically heterogenous with frequent phenotypic aberrancy and a cytotoxic phenotype in most cases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26379152      PMCID: PMC4644095          DOI: 10.1097/PAS.0000000000000503

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  63 in total

Review 1.  Primary Ki-1-positive T-cell lymphoma of the brain in a child.

Authors:  N Buxton; J Punt; M Hewitt
Journal:  Pediatr Neurosurg       Date:  1998-11       Impact factor: 1.162

2.  Primary central nervous system anaplastic large-cell lymphoma mimicking lymphomatosis cerebri.

Authors:  Toshiya Sugino; Takeshi Mikami; Yukinori Akiyama; Masahiko Wanibuchi; Tadashi Hasegawa; Nobuhiro Mikuni
Journal:  Brain Tumor Pathol       Date:  2012-03-18       Impact factor: 3.298

Review 3.  Primary central nervous system lymphoma of T-cell origin: description of two cases and review of the literature.

Authors:  E Villegas; S Villà; A López-Guillermo; J Petit; T Ribalta; F Graus
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

4.  Primary central nervous system T-cell lymphoma.

Authors:  J M Gijtenbeek; M K Rosenblum; L M DeAngelis
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

5.  Primary cerebral anaplastic large cell lymphoma containing abundant reactive histiocytes and eosinophils. A case report and literature review.

Authors:  S S Chuang; W Huang; C N Lin; C C Chio; T C Tsai; C Y Li; C H Shen
Journal:  Pathol Res Pract       Date:  2001       Impact factor: 3.250

Review 6.  Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 7.  Primary Ki-1-positive T-cell lymphoma of the brain--an aggressive subtype of lymphoma: case report and review of the literature.

Authors:  R Goldbrunner; M Warmuth-Metz; J C Tonn; G H Vince; K Roosen
Journal:  Surg Neurol       Date:  1996-07

8.  Primary T cell leptomeningeal lymphoma--successful treatment with systemic chemotherapy.

Authors:  K H Yeh; A L Cheng; H F Tien
Journal:  Oncology       Date:  1995 Nov-Dec       Impact factor: 2.935

Review 9.  Primary T-cell lymphoma of the cerebellum. A case report.

Authors:  K Kleopa; G Becker; W Roggendorf; H Reichmann
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

Review 10.  Large cell anaplastic (KI-1) brain lymphoma of T-cell genotype.

Authors:  W Paulus; M M Ott; H Strik; V Keil; H K Müller-Hermelink
Journal:  Hum Pathol       Date:  1994-11       Impact factor: 3.466

View more
  23 in total

1.  Brain biopsies requiring Creutzfeldt-Jakob disease precautions in the Republic of Ireland 2005-2016.

Authors:  F M Brett; S Looby; A Chalissery; D Chen; C Heaney; J Heffernan; F Cunningham; R Howley; T Loftus; H Kearney; M A Farrell
Journal:  Ir J Med Sci       Date:  2017-08-12       Impact factor: 1.568

2.  EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features.

Authors:  Alina Nicolae; Karthik A Ganapathi; Trinh Hoc-Tran Pham; Liqiang Xi; Carlos A Torres-Cabala; Nahid M Nanaji; Hongbin D Zha; Zhen Fan; Sybil Irwin; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

3.  Peripheral T-Cell Lymphomas Involving the Central Nervous System: A Report From the Czech Lymphoma Study Group Registry.

Authors:  Heidi Mocikova; Robert Pytlík; Katerina Benesova; Andrea Janikova; Juraj Duras; Alice Sykorova; Katerina Steinerova; Vit Prochazka; Vit Campr; David Belada; Marek Trneny
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

Review 4.  Intravascular large B-cell lymphoma presenting clinically as rapidly progressive dementia.

Authors:  F M Brett; D Chen; T Loftus; Y Langan; S Looby; S Hutchinson
Journal:  Ir J Med Sci       Date:  2017-07-19       Impact factor: 1.568

Review 5.  Central Nervous System Involvement in Peripheral T Cell Lymphoma.

Authors:  Dai Chihara; Yasuhiro Oki
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

Review 6.  Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Authors:  Ashley E Aaroe; Kathryn S Nevel
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.945

Review 7.  Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification.

Authors:  Parwiz J Siaghani; Joo Y Song
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

8.  EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline.

Authors:  Francesca M Brett; Richard Flavin; Daphne Chen; Teresa Loftus; Seamus Looby; Allan McCarthy; Cillian de Gascun; Elaine S Jaffe; Nurul Nor; Mohsen Javadpour; Dominick McCabe
Journal:  Hum Pathol (N Y)       Date:  2017-11

9.  Magnetic Resonance Imaging Characteristics of Primary Central Nervous System T-cell Lymphoma.

Authors:  Qing Zhao; Lin-Shu Zeng; Xiao-Li Feng; Hong-Mei Zhang
Journal:  Chin Med J (Engl)       Date:  2017-02-05       Impact factor: 2.628

Review 10.  New developments in the pathology of malignant lymphoma. A review of the literature published from September 2015-December 2015.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2016-02-22       Impact factor: 0.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.